Cost-Effectiveness Analysis of Recombinant Factor VIII Fc-Fusion Protein (rFVIIIFc) for the Treatment of Severe Hemophilia A in Italy Incorporating Real-World Dosing and Joint Health Data

被引：0
|
作者：
Ash Bullement
Samuel Thomas McMordie
Anthony James Hatswell
Nanxin Li
Koo Wilson
机构：
[1] Delta Hat,
[2] University College London,undefined
[3] Bioverativ,undefined
[4] a Sanofi Company,undefined
[5] Swedish Orphan Biovitrum AB (publ),undefined
来源：
PharmacoEconomics - Open | 2020年 / 4卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：133 / 142
页数：9
相关论文
共 50 条
  • [1] Cost-Effectiveness Analysis of Recombinant Factor VIII Fc-Fusion Protein (rFVIIIFc) for the Treatment of Severe Hemophilia A in Italy Incorporating Real-World Dosing and Joint Health Data
    Bullement, Ash
    McMordie, Samuel Thomas
    Hatswell, Anthony James
    Li, Nanxin
    Wilson, Koo
    PHARMACOECONOMICS-OPEN, 2020, 4 (01) : 133 - 142
  • [2] Longitudinal modified hemophilia joint health scores (mHJHS) outcomes with recombinant factor VIII Fc fusion protein (rFVIIIFc) prophylaxis in subjects with severe hemophilia A
    Oldenburg, Johannes
    Kulkarni, Roshni
    Srivastava, Alok
    Mahlangu, Johnny
    Lethagen, Stefan
    Tsao, Elisa
    Jain, Nisha
    HAEMOPHILIA, 2016, 22 : 40 - 40
  • [3] Dosing regimens before and following long-term treatment with recombinant factor VIII Fc fusion protein (rFVIIIFc) in children with severe hemophilia A
    Nolan, Beatrice
    Liesner, Raina
    Young, Guy
    Mahlangu, Johnny
    Pasi, K. John
    Lethagen, Stefan
    Cristiano, Lynda M.
    Yuan, Huixing
    Pierce, Glenn F.
    Allen, Geoffrey
    HAEMOPHILIA, 2016, 22 : 48 - 49
  • [4] Dosing regimens before and following long-term treatment with recombinant factor VIII Fc fusion protein (rFVIIIFc) in adults and adolescents with severe hemophilia A
    Konkle, Barbara A.
    Pasi, K. John
    Perry, David J.
    Mahlangu, Johnny
    Rangarajan, Savita
    Hanabusa, Hideji
    Pabinger, Ingrid
    Lethagen, Stefan
    Cristiano, Lynda M.
    Yuan, Huixing
    Pierce, Glenn F.
    Allen, Geoffrey
    HAEMOPHILIA, 2016, 22 : 44 - 44
  • [5] Real-world data of immune tolerance induction (ITI) using recombinant factor VIII Fc fusion protein (rFVIIIFc) in subjects with severe hemophilia A with inhibitors at high risk for ITI failure
    Carcao, M.
    Shapiro, A.
    Hwang, N.
    Pipe, S.
    Ahuja, S.
    Lieuw, K.
    Staber, J.
    Belletrutti, M.
    Sun, H.
    Ding, H.
    Wang, M.
    Price, V.
    Steele, M.
    Tsao, E.
    Feng, J.
    Al-Khateeb, Z.
    Dumont, J.
    Jain, N.
    HAEMOPHILIA, 2019, 25 : 15 - 16
  • [6] Cost-effectiveness analysis of recombinant factor IX Fc fusion protein compared with recombinant factor IX for the treatment of moderate-severe to severe hemophilia B in China
    Zhou, Ting
    Wang, Shuyue
    Zhang, Yao
    Wu, Runhui
    Li, Hongchao
    PEDIATRIC BLOOD & CANCER, 2023, 70 (06)
  • [7] THE CLINICAL AND ECONOMIC IMPACT OF RECOMBINANT FACTOR VIII FC FUSION PROTEIN (RFVIIIFC) ON LONG-TERM JOINT HEALTH IN PEOPLE WITH HEMOPHILIA A (PWHA)
    Batt, K.
    Cockerham, A.
    Sacks, N.
    Jin, H.
    Nguyen, A. T. H.
    HAEMOPHILIA, 2022, 28 : 93 - 94
  • [8] Modified Haemophilia Joint Health Scores (MHJHS) Outcomes with Recombinant Factor VIII FC Fusion Protein (rFVIIIFc) Prophylaxis in Subjects with Severe Haemophilia A
    Oldenburg, J.
    Srivastava, A.
    Mahlangu, J.
    Blanchette, V.
    Kulkarni, R.
    Li, S.
    Tsao, E.
    Jain, N.
    HAEMOPHILIA, 2016, 22 : 68 - 69
  • [9] Longitudinal Analysis of Long-Term Safety and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Previously Treated Children with Severe Hemophilia a
    Young, Guy
    Liesner, Raina
    Pasi, K. John
    Nolan, Beatrice
    Lethagen, Stefan
    Cristiano, Lynda M.
    Tsao, Elisa
    Winding, Bent
    Mahlangu, Johnny
    BLOOD, 2016, 128 (22)
  • [10] Analysis of clinical target joint bleeding on prophylactic regimens with recombinant Factor VIII Fc fusion protein in patients with severe hemophilia A
    Kulkarni, Roshni
    Ragni, Margaret V.
    Baker, Ross I.
    Pasi, John
    Manco-Johnson, Marilyn J.
    Potts, James
    Brennan, Aoife
    Pierce, Glenn F.
    HAEMOPHILIA, 2014, 20 : 94 - 94
12345